CircBRIP1: a plasma diagnostic marker for non-small-cell lung cancer.

"Declarations Competing interestsThe authors declare no competing interests. Conflict of interestThe authors claim to have no conflicts of interest. Ethical approvalThis study was approved by the ethics committee of the Affiliated Hospital of Nantong University (ethics review report number: 2018-L055). The participants provided their written informed consent to participate in this study. This study did not involve any animal studies. Competing interests The authors declare no competing interests. Conflict of interest The authors claim to have no conflicts of interest."

"Funding This project was supported by the National Natural Science Foundation of China (no. 82272411, no. 82072363), Jiangsu Provincial Medical Key Discipline (Laboratory) (ZDXK202240) and Science and Technology Project of Jiangsu Province (BE2023741)."